Titanium dioxide powder deemed safe from causing cancer when inhaled, according to EJC confirmation - Titanium dioxide powder, when inhaled, is deemed safe from being cancer-causing, as rule by the ECJ.
The European Court of Justice (ECJ) in Luxembourg has made a significant decision regarding the classification of titanium dioxide powder. In a ruling on 1 August 2025, the ECJ confirmed the annulment of the European Commission's 2019 decision that classified titanium dioxide powder as potentially carcinogenic when inhaled.
This decision follows a series of legal challenges, including a 2022 ruling by the General Court that invalidated the 2019 classification by the European Commission. The Advocate General had previously advised the ECJ to reverse that General Court ruling, supporting the Commission's classification. However, the final ECJ decision sided with the annulment instead.
The EU Commission and France appealed the EU Court's ruling from November 2022 to the ECJ. The ruling upholds the decision that titanium dioxide powder is not classified as carcinogenic by inhalation.
This means that products containing titanium dioxide powder in the EU are not required to carry a warning label. It is important to note that this decision applies specifically to titanium dioxide powder and does not change the classification of titanium dioxide in other forms or for other uses.
Titanium dioxide powder is a substance used in various products, including paints. The ruling could potentially impact the production, distribution, and use of products containing titanium dioxide powder in the EU. It is significant for companies that use titanium dioxide powder in their products, as it may affect their labeling requirements.
The ECJ's ruling reinforces the importance of thorough evaluation of scientific studies in the classification process. The court ruled that the European Chemicals Agency had not considered all relevant aspects in its evaluation of a scientific study.
Several companies, including paint manufacturers, successfully challenged this classification in the EU Court. The ruling could mark a turning point in the regulation of chemicals in the EU, emphasising the need for careful and comprehensive scientific evaluation in the classification process.
- The ECJ's ruling in Luxembourg, which overturned the classification of titanium dioxide powder as potentially carcinogenic when inhaled, could have significant implications for the science and health-and-wellness community, as it underlines the importance of accurate scientific studies and evaluations in the classification process for medical-conditions related to inhaling substances.
- The recent decision by the European Court of Justice (ECJ) in Luxembourg, which deemed titanium dioxide powder as not carcinogenic when inhaled, could spur a renewed interest in the use of this substance in the health-and-wellness industry, particularly for those with medical-conditions, as the ruling suggests that it may not pose the same risks previously suspected.
